ELEVANCE HEALTH INC
ELVNYSETrading Snapshot
- Day Range
- $389.66 – $396.11
- 52-Week Range
- $274.84 – $436.24
- Volume
- $2.35B
- Avg Volume
- $2.53B
- Shares Outstanding
- 216.9M
- Next Earnings
- Nov 4, 2026
Fundamentals Snapshot
- Annual Revenue
- $199.13B
- Last Q Revenue
- $50.47B
- P/E Ratio
- 17.5
- P/S Ratio
- 0.4x
- EPS (TTM)
- $22.78
- Dividend Yield
- 1.74%
- Dilution (1yr)
- −4.0%
Why Investors Own ELV
- ✓High-growth profile — revenue up +13.3% YoY with expanding US Equity exposure.
- ✓Healthy economics — 72% gross margin and 8% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
ELEVANCE HEALTH INC
ELV
StockOtter · stockotter.spaceAbout ELEVANCE HEALTH INC
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
Elevance Health (NYSE:ELV) Issues FY 2026 Earnings Guidance
Elevance Health (NYSE: ELV - Get Free Report) issued an update on its FY 2026 earnings guidance on Saturday morning. The company provided earnings per share (EPS) guidance of 27.000- for the period, compared to the conse
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?
Here is how Elevance Health (ELV) and American Well Corporation (AMWL) have performed compared to their sector so far this year.
Corient Private Wealth LP Sells 28,940 Shares of Elevance Health, Inc. $ELV
Corient Private Wealth LP reduced its holdings in shares of Elevance Health, Inc. (NYSE: ELV) by 41.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commis
ELV or DHR: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical Services stocks have likely encountered both Elevance Health (ELV) and Danaher (DHR). But which of these two companies is the best option for those looking for undervalued stocks?
Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation
Elevance Health Inc. (NYSE:ELV) shares are jumping Thursday after the company reaffirmed its full-year 2026 earnings guidance ahead of a series of investor meetings. Here's what you should know.
California State Teachers Retirement System Raises Stake in Elevance Health, Inc. $ELV
California State Teachers Retirement System boosted its stake in shares of Elevance Health, Inc. (NYSE: ELV) by 37,390.0% in the undefined quarter, according to the company in its most recent disclosure with the SEC. The